Atlas Trials

Flumatinib Efficacy and Safety for New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Clinical trial NCT04591197 · UNKNOWN

Trial details

NCT number
NCT04591197
Sponsor
Nanfang Hospital, Southern Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Validity and Safety
Start date
2020-12-09
Primary completion
2024-01-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.